tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Little Green Pharma in Transformational Merger with Cannatrek to Build Cannabis Powerhouse

Story Highlights
  • Little Green Pharma will acquire Cannatrek in an all-share scheme, creating a vertically integrated medicinal cannabis group spanning Australia and Europe.
  • The merged company targets greater scale and profitability, with pro forma 2025 revenue of $112m and a platform for European-led growth and further expansion.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Little Green Pharma in Transformational Merger with Cannatrek to Build Cannabis Powerhouse

Claim 50% Off TipRanks Premium

Little Green Pharma Ltd. ( (AU:LGP) ) just unveiled an update.

Little Green Pharma has agreed to acquire 100% of Cannatrek via a scheme of arrangement, in a merger that will create a fully vertically integrated medicinal cannabis group with substantial operations across Australia and Europe. Under the deal, Cannatrek shareholders will initially own about 60.5% and existing LGP shareholders 39.5% of the combined company, with additional contingent value shares potentially lifting Cannatrek’s stake further, and both boards backing the transaction in the absence of a superior proposal. On a simple amalgamated 2025 basis, the merged group would have recorded $112 million in revenue, $13 million in adjusted EBITDA and $15 million in cash, with anticipated synergies from better use of manufacturing capacity in Australia and Denmark, combined clinic operations, and tighter cost management. Management positions the merger as a transformational step toward scaling up to compete in the rapidly growing European medicinal cannabis market and to build a platform for further international expansion through both acquisitions and organic growth, supported by Cannatrek’s stronger balance sheet.

The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.

More about Little Green Pharma Ltd.

Little Green Pharma Ltd is an ASX-listed medicinal cannabis company focused on the Australian and European markets, with operations spanning cultivation, GMP-certified manufacturing and packaging, distribution, and clinic and digital health channels. Its products and services are positioned in the regulated medicinal cannabis sector, where scale, brand recognition and distribution capability are increasingly critical for capturing market share and maintaining long-term competitiveness.

Average Trading Volume: 192,812

Technical Sentiment Signal: Sell

Current Market Cap: A$36.68M

Learn more about LGP stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1